73 related articles for article (PubMed ID: 23443776)
1. [Design, synthesis and activity assessment of aryl-substituent benzyl acid targeting HIV gp41].
Wang H; Chen Z; Qiu J; Yu X; Xie Y; Liu S
Nan Fang Yi Ke Da Xue Xue Bao; 2013 Feb; 33(2):221-4. PubMed ID: 23443776
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, and biological activity of a novel series of 2,5-disubstituted furans/pyrroles as HIV-1 fusion inhibitors targeting gp41.
Jiang S; Tala SR; Lu H; Zou P; Avan I; Ibrahim TS; Abo-Dya NE; Abdelmajeid A; Debnath AK; Katritzky AR
Bioorg Med Chem Lett; 2011 Nov; 21(22):6895-8. PubMed ID: 21978673
[TBL] [Abstract][Full Text] [Related]
3. Tannin inhibits HIV-1 entry by targeting gp41.
Lü L; Liu SW; Jiang SB; Wu SG
Acta Pharmacol Sin; 2004 Feb; 25(2):213-8. PubMed ID: 14769212
[TBL] [Abstract][Full Text] [Related]
4. Hydroxyl may not be indispensable for raltegravir: Design, synthesis and SAR Studies of raltegravir derivatives as HIV-1 inhibitors.
Wang Z; Wang M; Yao X; Li Y; Qiao W; Geng Y; Liu Y; Wang Q
Eur J Med Chem; 2012 Apr; 50():361-9. PubMed ID: 22369862
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-HIV-1 activity of new MKC-442 analogues with an alkynyl-substituted 6-benzyl group.
Aly YL; Pedersen EB; La Colla P; Loddo R
Arch Pharm (Weinheim); 2007 May; 340(5):225-35. PubMed ID: 17464964
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anti-HIV activity evaluation of novel 2,4-disubstituted 7-methyl-1,1,3-trioxo-2,4-dihydro-pyrazolo-[4,5-e][1,2]thiadiazines.
Liu XY; Yan RZ; Wang Y; Zhan P; De Clercq E; Pannecouque C; Witvrouw M; Molina MT; Vega S
Arch Pharm (Weinheim); 2008 Apr; 341(4):216-22. PubMed ID: 18266290
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and structure-activity relationship of a novel series of 2-aryl 5-(4-oxo-3-phenethyl-2-thioxothiazolidinylidenemethyl)furans as HIV-1 entry inhibitors.
Katritzky AR; Tala SR; Lu H; Vakulenko AV; Chen QY; Sivapackiam J; Pandya K; Jiang S; Debnath AK
J Med Chem; 2009 Dec; 52(23):7631-9. PubMed ID: 19746983
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationships: analogues of the dicaffeoylquinic and dicaffeoyltartaric acids as potent inhibitors of human immunodeficiency virus type 1 integrase and replication.
King PJ; Ma G; Miao W; Jia Q; McDougall BR; Reinecke MG; Cornell C; Kuan J; Kim TR; Robinson WE
J Med Chem; 1999 Feb; 42(3):497-509. PubMed ID: 9986720
[TBL] [Abstract][Full Text] [Related]
9. Computer-aided design, synthesis, and biological activity evaluation of potent fusion inhibitors targeting HIV-1 gp41.
Tan JJ; Zhang B; Cong XJ; Yang LF; Liu B; Kong R; Kui ZY; Wang CX; Hu LM
Med Chem; 2011 Jul; 7(4):309-16. PubMed ID: 21568877
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of 2-(aminocarbonylmethylthio)-1H-imidazoles as novel Capravirine analogues.
Loksha YM; el-Barbary AA; el-Badawi MA; Nielsen C; Pedersen EB
Bioorg Med Chem; 2005 Jul; 13(13):4209-20. PubMed ID: 15896963
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and evaluation of indole compounds as novel inhibitors targeting Gp41.
Zhou G; Wu D; Hermel E; Balogh E; Gochin M
Bioorg Med Chem Lett; 2010 Mar; 20(5):1500-3. PubMed ID: 20153190
[TBL] [Abstract][Full Text] [Related]
12. [Isolation and characterization of the anti-HIV active component from Eucommia ulmoides].
Lv L; Sun YR; Xu W; Liu SW; Rao JJ; Wu SG
Zhong Yao Cai; 2008 Jun; 31(6):847-50. PubMed ID: 18998566
[TBL] [Abstract][Full Text] [Related]
13. A natural theaflavins preparation inhibits HIV-1 infection by targeting the entry step: potential applications for preventing HIV-1 infection.
Yang J; Li L; Tan S; Jin H; Qiu J; Mao Q; Li R; Xia C; Jiang ZH; Jiang S; Liu S
Fitoterapia; 2012 Mar; 83(2):348-55. PubMed ID: 22155187
[TBL] [Abstract][Full Text] [Related]
14. [1,2,6-tri-O-galloyl-beta-D-glucopyranose inhibits gp41-mediated HIV envelope fusion with target cell membrane].
Sun W; Wang HT; Xia CL; Wu SG; Jiang SB; Jiang ZH; Liu SW
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jul; 28(7):1127-31. PubMed ID: 18676243
[TBL] [Abstract][Full Text] [Related]
15. Non-nucleoside HIV-1 reverse-transcriptase inhibitors. Part 10. Synthesis and anti-HIV activity of 5-alkyl-6-(1-naphthylmethyl)pyrimidin-4(3H)-ones with a mono- or disubstituted 2-amino function as novel 'dihydro-alkoxy-benzyl-oxopyrimidine' (DABO) analogues.
Wang Y; Chen FE; Balzarini J; De Clercq E; Pannecouque C
Chem Biodivers; 2008 Jan; 5(1):168-76. PubMed ID: 18205120
[TBL] [Abstract][Full Text] [Related]
16. Structure-based design of substituted biphenyl ethylene ethers as ligands binding in the hydrophobic pocket of gp41 and blocking the helical bundle formation.
Liu B; Joseph RW; Dorsey BD; Schiksnis RA; Northrop K; Bukhtiyarova M; Springman EB
Bioorg Med Chem Lett; 2009 Oct; 19(19):5693-7. PubMed ID: 19699090
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of caffeoyl-anilides as portmanteau inhibitors of HIV-1 integrase and CCR5.
Bodiwala HS; Sabde S; Gupta P; Mukherjee R; Kumar R; Garg P; Bhutani KK; Mitra D; Singh IP
Bioorg Med Chem; 2011 Feb; 19(3):1256-63. PubMed ID: 21227704
[TBL] [Abstract][Full Text] [Related]
18. Design and evaluation of antiretroviral peptides corresponding to the C-terminal heptad repeat region (C-HR) of human immunodeficiency virus type 1 envelope glycoprotein gp41.
Soonthornsata B; Tian YS; Utachee P; Sapsutthipas S; Isarangkura-na-Ayuthaya P; Auwanit W; Takagi T; Ikuta K; Sawanpanyalert P; Kawashita N; Kameoka M
Virology; 2010 Sep; 405(1):157-64. PubMed ID: 20580393
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and potent anti-HIV-1 activity of novel 6-benzyluracil analogues of 1-[(2-hydroxyethoxy)methyl]-6-(phenylthio)thymine.
Danel K; Larsen E; Pedersen EB; Vestergaard BF; Nielsen C
J Med Chem; 1996 Jun; 39(12):2427-31. PubMed ID: 8691437
[TBL] [Abstract][Full Text] [Related]
20. Geometrically and conformationally restrained cinnamoyl compounds as inhibitors of HIV-1 integrase: synthesis, biological evaluation, and molecular modeling.
Artico M; Di Santo R; Costi R; Novellino E; Greco G; Massa S; Tramontano E; Marongiu ME; De Montis A; La Colla P
J Med Chem; 1998 Oct; 41(21):3948-60. PubMed ID: 9767632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
